Funding for this research was provided by:
Ouest Valorisation (SDSP-DV2896/LATIM; Ouest Valorisation.)
Article History
Received: 11 December 2020
Accepted: 13 April 2021
First Online: 22 April 2021
Declarations
:
: ELH, SN, DV are co-inventors of the technique (Body surface optical imaging for respiratory monitoring; European patent application No. 19306417.7–1115. ELH is a co-founder and shareholder of Oxynov Inc., a Canadian R&D company; he is also consultant for GE Healthcare, Smiths, Sedana Medical. VP, SN, DV have no other conflicts of interest.
: Data analysis was performed within the ReaSTOC data-warehousing project including all patients admitted to our adult medical ICU (ClinicalTrials.gov identifier NCT02893462). The protocol was approved by our local ethics committee and written informed consent was waived, according to French legislation.
: Not applicable.